Emerging Risk Factors Collaboration. JAMA 2009;302:412-23

Slides:



Advertisements
Similar presentations
Literature Search Strategy Used for the MEDLINE Database Gami AS, et al. J Am Coll Cardiol 2007;49:
Advertisements

PAD Rehabilitation Toolkit A Guide for Healthcare Professionals Healthy Steps for Peripheral Artery Disease (PAD) Developed by AACVPR and the Vascular.
Description of Each Study in the Cross Trial Safety Analysis Solomon SD, et al. Circulation 2008 [Epub Mar 31]
WHO CVD Atlas WHO Stroke Atlas The Burden of CVD in Asia: Stroke Deaths by Country,
European Heart Journal 2010; 31:
Slide Source: Lipids Online Slide Library Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) 5804 patients aged 70–82.
VBWG IDEAL: The Incremental Decrease in End Points Through Aggressive Lipid Lowering Study.
Stroke The overall age-adjusted mortality rate (AAMR) for stroke in Texas declined from 66.3 per 100,000 in 1999 to 52.1 per 100,000 in The decrease.
 Alcohol thins your blood so less blood clots  Alcohol also helps with stress.
HPS: Heart Protection Study Purpose To determine whether simvastatin reduces mortality and vascular events in patients with and without coronary disease,
Introduction Lipoprotein(a) [Lp(a)]
Flow Diagram of the Main HOPE Trial and the HOPE-TOO Trial Extension The HOPE and HOPE-TOO Trial Investigators JAMA. 2005;293:
Aim To determine the effects of a Coversyl- based blood pressure lowering regimen on the risk of recurrent stroke among patients with a history of stroke.
Antithrombotic Trialists’ (ATT) Collaboration. Lancet 2009;373:
Long-term mortality after acute stroke  Stroke is a leading cause of mortality: 6 million fatal events annually worldwide.  Mainly affects elderly, but.
Lancet 373: , 2009 Baseline Characteristics of Participants and Study Design of Clinical Trials to Compare Intensive glucose- lowering versus.
Baseline Characteristics of 987 Individuals With Stable Coronary Heart Disease by Amino Terminal Fragment of the Prohormone Brain-Type Natriuretic Peptide.
Enrollment and Outcomes Duckworth W, et al. N Engl J Med 2009;360:
Date of download: 5/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Causal Assessment of Serum Urate Levels in Cardiometabolic.
Date of download: 6/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Major Lipids, Apolipoproteins, and Risk of Vascular.
Flow Diagram of the Trial Selection Process Jeffrey S. Berger et al, JAMA. 2006;295:
Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Glycated Hemoglobin Measurement and Prediction of.
Everolimus-eluting Bioresorbable Vascular Scaffolds in Patients with Coronary Artery Disease: ABSORB III Trial 2-Year Results Stephen G. Ellis, MD,
From: Risks of Cardiovascular Adverse Events and Death in Patients with Previous Stroke Undergoing Emergency Noncardiac, Nonintracranial Surgery:The Importance.
Copyright © 2012 American Medical Association. All rights reserved.
American Heart Month Resources:
Should we move from Lipids to Lipoproteins, from Dyslipidemia to Dyslipoproteinemia in future guidelines for CVD?
INTERNATIONAL CONGRESS OF CAD
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Patient populations by study group figure 10
Baseline Characteristics of Women and Men in Whom Coronary Heart Disease Developed during Follow-up and Matched Controls - A Jennifer K. Pai et al. N.
Copyright © 2015 by the American Osteopathic Association.
HDL cholesterol and cardiovascular risk Epidemiological evidence
Copyright © 2012 American Medical Association. All rights reserved.
HDL cholesterol and cardiovascular risk
TNT: Baseline and final LDL cholesterol levels
Progress and Promise in RAAS Blockade
Cardiovascular disease
The Hypertension in the Very Elderly Trial (HYVET)
Volume 375, Issue 9709, Pages (January 2010)
Cardiovascular disease
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Age-specific relevance of usual blood pressure to vascular mortality
Lowering of SBP by 20 mm Hg Reduces Cardiovascular Risk by Half
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies 
Elliott P, et al. JAMA 2009;302:37-48.
Nat. Rev. Cardiol. doi: /nrcardio
Volume 375, Issue 9725, Pages (May 2010)
Volume 68, Issue 5, Pages (November 2005)
Baseline Characteristics of Cardiovascular Risk Factors and Selected Dietary Variables in a Cohort of 22,881 Men and 35,091 Women to Quintile of Fish Intakes.
Baseline Characteristics by Baseline N-BNP Level
Berger JS, et al. JAMA 2009;301:
Estimated 5-year rate of a first major vascular event (MVE), major coronary event (MCE),or vascular death in univariate and multivariate risk subgroups.
A.V. Khera et al. N Engl J Med 2011;364:127-35
Cause of death Treatment-arm events, % (n=45 054)
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Baseline Characteristics of the Subjects*
Volume 383, Issue 9921, Pages (March 2014)
Baseline Characteristics
Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.
Strategies for Optimizing Glycemic Control and Cardiovascular Prognosis in Patients With Type 2 Diabetes Mellitus  James H. O'Keefe, MD, Mohammad Abuannadi,
Predictive value of the National Institutes of Health Stroke Scale and the Mini-Mental State Examination for neurologic outcome after coronary artery.
Flow chart of search strategy
Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm
Genetic predisposition to CHD modifies the increased CHD risk associated with smoking (*) ORs adjusted for age, gender, total energy intake, alcohol intake,
Adjusted prevalence of CHD, atrial fibrillation, and stroke by sex and ethnic group. Numbers for sex are adjusted for age and clustering within practices.
Risk differences for incident stroke, coronary heart disease (CHD), and cardiovascular mortality (per 1000 person-years) by clinical risk factor in the.
Risk for cardiovascular disease and all-cause death according to RHR: (A) as categorical variable (HR≥75 bpm vs HR
Orly Vardeny et al. JCHF 2016;4:
Alcohol, Other Drugs, and Health: Current Evidence May–June 2019
Presentation transcript:

Emerging Risk Factors Collaboration. JAMA 2009;302:412-23

Literature Search and Study Selection Emerging Risk Factors Collaboration. JAMA 2009;302:412-23

Characteristics of 36 Prospective Studies Contributing Data to the Current Analysis Emerging Risk Factors Collaboration JAMA 2009;302:412-23

Summary of Available Data and Correlates of Lp(a) Levels Emerging Risk Factors Collaboration. JAMA 2009;302:412-23

Risk Ratios for Coronary Heart Disease, Ischemic Stroke, or Nonvascular Death by Quantile of Usual Lp(a) Level Emerging Risk Factors Collaboration. JAMA 2009;302:412-23

Risk Ratios for Coronary Heart Disease and Ischemic Stroke per 3 Risk Ratios for Coronary Heart Disease and Ischemic Stroke per 3.5-Fold (1-SD) Higher Usual Lipoprotein(a) Levels With Progressive Adjustment for Usual Levels of Confoundersa Emerging Risk Factors Collaboration. JAMA 2009;302:412-23

Risk Ratios for Vascular and Nonvascular Outcomes per 3 Risk Ratios for Vascular and Nonvascular Outcomes per 3.5-Fold (1-SD) Higher Usual Lp(a) Level, Adjusted for Cardiovascular Risk Factors Emerging Risk Factors Collaboration. JAMA 2009;302:412-23

Risk Ratios for Coronary Heart Disease per 3 Risk Ratios for Coronary Heart Disease per 3.5-Fold (1-SD) Higher Usual Lp(a) Level, by Age and Thirds of Individual Characteristics Emerging Risk Factors Collaboration. JAMA 2009;302:412-23

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.